Targeted PLGA microparticles as a novel concept for treatment of lactose intolerance

Journal of Controlled Release

Volumn 147, Issue 2, 2010, Pages 187-192

  Ratzinger, Gerda ^a   Wang, Xueyan ^a   Wirth, Michael ^a   Gabor, Franz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

galactosidase; Lactose intolerance; Microparticles; PLGA; Targeting; WGA

Indexed keywords

GALACTOSIDASES; LACTOSE INTOLERANCE; MICRO-PARTICLES; PLGA; TARGETING; WGA;

ALDEHYDES; BIODEGRADABLE POLYMERS; BIOMIMETICS; CYCLOHEXANE; ENZYME ACTIVITY; ENZYMES; FUNCTIONAL POLYMERS; MONOLAYERS; ORGANIC POLYMERS;

SUGARS;

1,6 HEXANEDIAMINE; AMINOCAPROIC ACID; BETA GALACTOSIDASE; CYANAMIDE; DRUG CARRIER; GLUTARALDEHYDE; MUCIN; POLYETHYLENEIMINE; POLYGLACTIN; WHEAT GERM AGGLUTININ;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; BIOMIMETICS; CELL INTERACTION; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMOBILIZATION; INTESTINE EPITHELIUM; KLUYVEROMYCES LACTIS; LACTOSE INTOLERANCE; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMALS; BETA-GALACTOSIDASE; CACO-2 CELLS; CELL ADHESION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; KLUYVEROMYCES; LACTIC ACID; LACTOSE INTOLERANCE; MUCINS; PARTICLE SIZE; POLYGLYCOLIC ACID; SURFACE PROPERTIES; SWINE; WHEAT GERM AGGLUTININS;

EID: 77957021223     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.04.017     Document Type: Article

References (18)

1. Harrington L.K., Mayberry J.F. A re-appraisal of lactose intolerance. Int. J. Clin. Pract. 2008, 62:1541-1546.
2. Noren O., Sjöström H. Structure, biosynthesis and regulation of lactase-phlorizin hydrolase. Scand. J. Nutr. 2001, 45:156-160.
3. Matthews S.B., Waud J.P., Roberts A.G., Campbell A.K. Systemic lactose intolerance: a new perspective on an old problem. Postgrad. Med. J. 2005, 81:167-173.
4. Panesar P.S., Panesar R., Singh R.S., Kennedy J.F., Kumar H. Microbial production, immobilization and applications of β-D-galactosidase. J. Chem. Technol. Biotechnol. 2006, 81:530-543.
5. Grosova Z., Rosenberg M., Rebros M. Perspectives and applications of immobilised β-galactosidase in food industry - a review. Czech. J. Food. Sci. 2008, 26:1-14.
6. Montalto M., Nucera G., Santoro L., Curigliano V., Vastola M., Covino M., Cuoco L., Manna R., Gasbarrini A., Gasbarrini G. Effect of exogenous β-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study. Eur. J. Clin. Nutr. 2005, 59:489-493.
7. Lin M.-Y., Dipalma J.A., Martini M.C., Gross C.J., Harlander S.K., Savaiano D.A. Comparative effects of exogenous lactase (β-galactosidase) preparations on in vivo lactose digestion. Dig. Dis. Sci. 1993, 38:2022-2027.
8. Ramirez F.C., Lee K., Graham D.Y. All lactase preparations are not the same: Results of a prospective, randomized, placebo-controlled trial. Am. J. Gastroenterol. 1994, 89:566-570.
9. Ertl B., Heigl F., Wirth M., Gabor F. Lectin-mediated bioadhesion: preparation, stability and caco-2 binding of wheat germ agglutinin-functionalized Poly(D, L-lactic-co-glycolic acid)-microspheres. J. Drug. Target. 2000, 8:173-184.
10. Dickson R.C., Dickson L.R., Markin J.S. Purification and properties of an inducible β-galactosidase isolated from the yeast Kluyveromyces lactis. J. Bacteriol. 1979, 137:51-61.
11. http://www.fda.gov/Food/FoodIngredientsPackaging/ucm084292.htm.
12. Gabor F., Bogner E., Weissenboeck A., Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv. Drug. Deliv. Rev. 2004, 56:459-480.
13. Gabor F., Wirth M. Lectin-mediated drug delivery: fundamentals and perspectives. STP Pharma Sci. 2003, 13:3-16.
14. Weissenboeck A., Wirth M., Gabor F. WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells. J. Control. Release 2004, 99:383-392.
15. Fillafer C., Ratzinger G., Neumann J., Guttenberg Z., Dissauer S., Lichtscheidl I.K., Wirth M., Gabor F., Schneider M.F. An acoustically-driven biochip - impact of flow on the cell-association of targeted drug carriers. Lab Chip 2009, 9:2782-2788.
16. Craven G.R., Steers E., Anfinsen C.B. Purification, composition and molecular weight of the β-galactosidase of Escherichia coli K12. J. Biol. Chem. 1965, 240:2468-2477.
17. Güll I., Wirth M., Gabor F. Development of a sensitive and reliable ELISA for quantification of wheat germ agglutinin. J. Immunol. Meth. 2007, 318:20-29.
18. Desai M.P., Labhasetwar V., Walter E., Levy R.J., Amidon G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 1997, 14:1568-1573.